Undervalued Stocks Based On Cash Flows

Results

780

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

780 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
3150
JP¥2,462.00-4.4%1.7%JP¥56.9bn/a11.310.4%3.8%Commercial Services
601567
CN¥15.85-2.1%-34.7%CN¥22.2bCN¥35.7723.345.6%4.0%Capital Goods
AXS
UK£0.71-0.3%18.3%UK£172.7mUK£1.1431.237.8%n/aMaterials
MUR
zł38.850.1%-2.8%zł1.6bzł50.778.412.4%12.6%Real Estate Management and Development
CTT
SEK 138.405.2%-34.1%SEK 1.7bn/a47.555.3%1.7%Capital Goods
A126340
₩70,300.00-1.0%146.7%₩504.8b₩160,000.005.577.6%n/aTech
FDV
AU$0.32-3.0%-8.6%AU$139.4mAU$0.512.587.3%n/aMedia
OCFC
US$19.15-3.6%8.6%US$1.9bUS$22.080.865.1%4.2%Banks
KOSKI
€8.501.2%-4.3%€204.8m€8.5038.443.4%1.6%Materials
AFE
R107.68-12.5%-2.1%R11.6bR132.0029.442.8%2.4%Materials
HSSEB
RM 0.53-2.8%-19.7%RM 269.5mRM 0.5917.337.6%2.8%Capital Goods
CDG
€3.07-0.3%143.7%€28.7m€3.1746.437.4%1.1%Media
9245
JP¥2,140.000.7%25.1%JP¥11.4bn/a15.932.7%2.0%Commercial Services
AZN
UK£117.02-2.8%2.3%UK£181.5bUK£156.6923.413.7%2.0%Pharmaceuticals & Biotech
STIL
SEK 233.00-0.4%3.1%SEK 2.1bSEK 285.7528.822.3%0%Healthcare
ALDMS
€1.08-1.4%-17.0%€27.9m€2.200.571.8%n/aHealthcare
CBRAIN
DKK 52.906.4%-76.0%DKK 1.0bDKK 82.5024.025.6%1.9%Software
TEM
US$54.6116.9%-21.6%US$10.0bUS$62.646.945.0%n/aPharmaceuticals & Biotech
LITE
US$932.4712.9%675.6%US$72.7bUS$1,148.30188.236.7%n/aTech
LHV1T
€3.350.1%-5.4%€1.1b€4.401.521.1%5.1%Banks
BRG
NOK 156.00-2.1%-23.7%NOK 15.5bNOK 178.2092.054.7%3.0%Materials
FLNC
US$13.20-7.2%74.8%US$2.4bUS$16.610.765.2%n/aCapital Goods
A451760
₩8,250.008.3%-10.3%₩134.0bn/a1.6135.7%n/aCapital Goods
NEWA B
SEK 92.40-1.9%-21.6%SEK 12.3bSEK 114.2516.020.6%3.2%Consumer Durables
Page 1 of 22